维普中文期刊产品整合服务
678篇 您的检索式:作者名="HERBERT P"
    题名 作者 年代 出处 被引量
1Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival显示文摘BACKGROUND: In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified according to their clinical status and tumor extent to different regional modalities or to best supportive care. The present study evaluated all patients who were stratified to repeated transarterial chemoembolization (TACE) from 1999 until 2003 in terms of tumor response, toxicity, and survival. A moderate embolizing approach was chosen using a combination of degradable starch microspheres (DSM) and iodized oil (Lipiodol) in order to combine anti-tumoral efficiency and low toxicity. METHODS: Fourty-seven patients were followed up prospectively. TACE treatment consisted of cisplatin (50 mg/m2), doxorubicin (50 mg/m2), 450-900 mg DSM, and 5-30 ml Lipiodol. DSM and Lipiodol were administered according to tumor vascularization. Patient characteristics,toxicity, and complications were outlined. In multivariate regression analyses of pre-treatment variables from a prospective database, predictors for tumor response and survival after TACE were determined. RESULTS: 112 TACE courses were performed (2.4±1.5 courses per patient). Mean maximum tumor size was 75 (± 43) mm, in 68% there was bilobar disease. Best response to TACE treatment was: progressive disease (PD) 9%, stable disease (SD) 55%, partial remission (PR) 36%, and complete remission (CR) 0%. Multivariate regression analyses identified tumor size ≤75 mm, tumor number ≤5, and tumor hypervascularization as predictors for PR. The overall 1-, 2-, and 3-year-survival rates were 75%, 59%, and 41%, respectively, and the median survival was 26 months. Low α-fetoprotein levels (<400 ng/ml) (Odds ratio=3.3) and PR as best response to TACE (Odds ratio=6.7) were significantly associated with long term survival (>30 months, R2=36%). Grade 3 toxicity occurred in 7.1% (n=8), and grade 4 toxicity in 3.6% (n=4) of all courses in terms of reversible leukopenia and thrombocytopenia. The incidence of major complications was 5.4% (n=6). All complications were managed conservatively. The mortality within 6 weeks after TACE was 2.1% (one patient). CONCLUSIONS: DSM and Lipiodol were combined successfully in the palliative TACE treatment of advanced HCC resulting in high rates of tumor response and survival at limited toxicity. Favourable tumor response was associated with tumor extent and vascularization. TACE using DSM and Lipiodol can be considered a suitable palliative measure in patients who might not tolerate long acting embolizing agents.Timm D Kirchhoff Joerg S Bleck Arne Dettmer Ajay Chavan Herbert Rosenthal Sonja Merkesdal Bernd Frericks Lars Zender Nisar P Malek Tim F Greten Stefan Kubicka Michael P Manns Michael Galanski 2007Hepatobiliary & Pancreatic Diseases International2007,6,3:15
2Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma显示文摘瞄准:为病人评估经皮的乙醇注射(PEI ) 的治疗效果与先进, non-resectable HCC 与 transarterial chemoembolisation 的联合相比(不作声) 并且重复单个会议的 PEI,独自重复了单个会议的 PEI,重复不作声独自一个,或最好的支持的照顾。方法:在学习时期期间接受了 PEI 治疗的所有病人根据物理地位和肿瘤程度被包括并且成层到下列治疗形式之一:联合不作声并且重复单个会议的 PEI,独自重复了单个会议的 PEI,重复不作声独自一个,或最好的支持的照顾。包括Okuda分类,门静脉血栓的存在,腹水的存在,肿瘤的数字,最大的肿瘤直径,和假胆硷酯酶( CHE )的临床的参数的预示的价值,以及孩子呸上演, alpha-fetoprotein (法新社),发烧,复杂并发症的发生在这些组之间被估计并且比较。幸存用 Kaplan-Meier 被决定,多,变量回归分析。结果:所有病人的 1 年、 3 年的幸存是 73% 和 47% 。在亚群分析,联合不作声, PEI (1 ) 与更长的幸存被联系(1- , 3- , 5 年的幸存:90% , 52% ,和 43%) 与 PEI 治疗相比独自一个(2 )(1- , 3- , 5 年的幸存:65% , 50% ,和 37%) 。(3 ) 在起始的层化以后的第二等的 PEI 产出可比较的结果不作声(1- , 3- , 5 年的幸存:91% , 40% ,和 30%) 当在到最好的支持的照顾(4 ) 的层化以后的 PEI 与减少的幸存被联系时(1- , 3- , 5 年的幸存:50% , 23% , 12%) 。除了选择治疗形式,为更好的幸存的预言者是肿瘤数字(n < 5 ) ,肿瘤尺寸(< 5 厘米) ,在 PEI 前的没有腹水,和在 PEI 以后的稳定的假胆硷酯酶(P < 0.05 ) 。在在 PEI 以后的 2 wk 以内的死亡是 2.8%(n = 3 ) 。有 24 (8.9%) 主修在包括部分肝梗塞,焦点的肝坏死,和肝脓肿的 PEI 以后的复杂并发症。所有复杂并发症能非通过手术被管理。结论:重复单个会议的 PEI 在有以可接受、可管理的复杂并发症率的先进 HCC 的病人是有效的。病人们成层到联合不作声, PEI 能比那些独自成层到重复 PEI 期望更长的幸存。而且,有在好临床的地位的大或多重的肿瘤的病人可以也从联合获利不作声并且为第二等的 PEI 的再考虑。Arne Dettmer Timm D Kirchhoff Michael Gebel Lars Zender Nisar P Malek Bernhard Panning Ajay Chavan Herbert Rosenthal Stefan Kubicka Susanne Krusche Sonja Merkesdal Michael Galanski Michael P Manns Joerg S Bleck 2006World Journal of Gastroenterology2006,12,23:14
3HPV detection and measurement of HPV16 telomerase and survivin traseripts in coiposcopy clinic patients显示文摘Lanham S Herbert A Watt P 2001J Clin Pathol2001,54,4:1
4Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register显示文摘Lindahl H Malchau H Herberts P 2005J Arthroplasty2005,20,7:1
5Characterization of Microbial Community in Granular Sludge Treating Brewery Wastewater 显示文摘Liu W T Chanc O C Herbert H P 2002Water Res2002,,36:1
6The Swedish Total Hip Replacement Register显示文摘Malchau H Herberts P Eisler T 0,,2:1
7The mitogenic effect of H2O2 for vascular smooth muscle cells is mediated by anincrease of the affinity of basic fibroblast growth factor for its receptor显示文摘Herbert JM Bono F Savi P 1996FEBS Lett1996,395,1:1
8Clopidoga'el and ticlopidine:P2Y12 adenosine diphosphatereceptor antagonists for the prevention of atherothrombosis 显示文摘Savi P Herbert JM 2005Semin Thromb Hemost2005,31,:1
9The chemistry of side reactions and byproduct formation in the system NMMO/cellulose(loycell process)显示文摘Thomas R Anti E P Herbert S 2001Progress in Polymer Science2001,26,9:1
10Differential response of soybean yield components to the timing of light enrichment 显示文摘Mathew J P Herbert S J Zhang S H 2000Agronomy Journal2000,92,:1
11P2Y12,a new platelet ADP recep- tor, target of clopidogrel显示文摘Herbert JM Savi P 2003Semi Vas Med2003,3,2:1
12Highly crosslinkedpolyethylene does not reduce aseptic loosening in cemented THA10-year findings of a randomized study 显示文摘Johanson PE Digas G Herberts P 2012Clin Orthop RelatRes2012,470,11:1
13Role of HIF-lalpha in hypoxi- a-mediated apoptosis, cell proliferation and tumour angiogenesis 显示文摘Carmeliet P Dor Y Herbert JM 1998Nature1998,394,6692:1
14Breast hamartomas: clinicopathological and immunohistochemical studies of 24 cases 显示文摘Herbert M Sandbank J Liokumovich P 2002Histopathology2002,41,1:1
15The Deep Lunar Electrical Conductivity Profile:Structural and Thermal Inferences显示文摘Hood L L Herbert F Sonett C P 1982Journal of Geophysical Research1982,87,7:1
16In vitro activity of Ro 13-9904, cefuroxime, cefoxitin, and ampicitlin against Neisseria gonorrhoeae 显示文摘Yoshikawa TT Shibata SA Herbert P 1980Antimierob Agents Chemother1980,18,2:1
17Coupled groundwater flow and solute transport with fluid density strongly dependent upon concentration显示文摘 Jackson C P Lever D A 1988Water Resource Research1988,24,10:1
18Role of HIF-1 alpha in hypoxiamediated apoptosis,cell proliferation andtumour angiogenes 显示文摘Carmeliet P DorY Herbert JM 1998Nature1998,394,6692:1
19Differential response of soybean yield components to the timingof light enrichment显示文摘Mathew J P Herbert S J Zhang S H 2000Agrono- my Journal2000,92,:1
20Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis 显示文摘Carmeliet P Dor Y Herbert JM 1998Nature1998,394,6692:1
返回顶部 每页显示:
共34页 首页 上一页 第1页 下一页 末页 /34 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费